155 related articles for article (PubMed ID: 36451772)
1. Identification of KIF21B as a Biomarker for Colorectal Cancer and Associated with Poor Prognosis.
Xu S; Li Y; Huang H; Miao X; Gu Y
J Oncol; 2022; 2022():7905787. PubMed ID: 36451772
[TBL] [Abstract][Full Text] [Related]
2. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer.
Sun ZG; Pan F; Shao JB; Yan QQ; Lu L; Zhang N
Cancer Cell Int; 2020; 20():233. PubMed ID: 32536821
[TBL] [Abstract][Full Text] [Related]
3. Targeting kinesin family member 21B by miR-132-3p represses cell proliferation, migration and invasion in gastric cancer.
Liu B; Qiang L; Guan B; Ji Z
Bioengineered; 2022 Apr; 13(4):9006-9018. PubMed ID: 35341446
[TBL] [Abstract][Full Text] [Related]
4. KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway.
Ni S; Li J; Qiu S; Xie Y; Gong K; Duan Y
Front Oncol; 2020; 10():606765. PubMed ID: 33585227
[TBL] [Abstract][Full Text] [Related]
5. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Hou W; Kong L; Hou Z; Ji H
BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
[TBL] [Abstract][Full Text] [Related]
6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
7. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
[TBL] [Abstract][Full Text] [Related]
8. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
9. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma.
Zhao HQ; Dong BL; Zhang M; Dong XH; He Y; Chen SY; Wu B; Yang XJ
World J Gastrointest Oncol; 2020 Mar; 12(3):276-288. PubMed ID: 32206178
[TBL] [Abstract][Full Text] [Related]
10. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
Front Oncol; 2022; 12():878546. PubMed ID: 35712475
[TBL] [Abstract][Full Text] [Related]
12. SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer.
Dai W; Feng J; Hu X; Chen Y; Gu Q; Gong W; Feng T; Wu J
Cancer Cell Int; 2021 Feb; 21(1):106. PubMed ID: 33632211
[TBL] [Abstract][Full Text] [Related]
13. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
14.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
15. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
[No Abstract] [Full Text] [Related]
16. The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers.
Cao Y; Deng S; Yan L; Gu J; Mao F; Xue Y; Qin L; Jiang Z; Cai W; Zheng C; Nie X; Liu H; Sun Z; Shang F; Tao K; Wang J; Wu K; Zhu B; Cai K
Front Genet; 2022; 13():818994. PubMed ID: 35444692
[TBL] [Abstract][Full Text] [Related]
17. KIAA1522 is a new biomarker of promoting the tumorigenesis and distant metastasis of colorectal carcinoma.
Yi X; Hu C; Zhang C; Shao K; Sun H; Jiang Y; Sun N; Zhi X
Cell Signal; 2022 Feb; 90():110202. PubMed ID: 34826587
[TBL] [Abstract][Full Text] [Related]
18. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
20. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
